Dietary galactose enhances CD8+ T-cell immunity and suppresses tumor progression by reprogramming hepatocyte metabolism to induce IGFBP-1 production, thereby limiting IGF-1 signaling–dependent T cell exhaustion. Here, CD8A is linked to neoplasm.